Soft Tissue and Bone Diameter in Children and Adults for Intraosseus Access

Assessment of Soft Tissue and Bone Diameter for Intraosseus Access in Children and Adults

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03082066

Enrollment

500

Registered

2017-03-17

Start date

2017-03-15

Completion date

2018-03-20

Last updated

2021-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Infection, Emergencies, Infusion Site Injury

Keywords

bone access, intraosseus needle, resuscitation, infusion, volume therapy, emergency

Brief summary

Retrospective observational study: Soft tissue and bone diameters are assessed in MRI and CT scans of patients. Data is compared with recommendations of intraosseus needle producers to assess whether the information provided by the producers can be optimised. Study sites are head of humerus bone, distal femur, proximal and distal tibia in accordance with recommended intraosseus access sites. Primary and secondary outcome parameters will be assessed at one time only, i.e. when the patient has received MRI or CT scan for the diagnostic work up of their primary disease. Data collection for a given patient in this study can be completed within one session, e.g. 5-10 minutes. No additional investigation is required for this retrospective study.

Detailed description

Retrospective observational single centre study: Soft tissue and bone diameters are assessed in MRI and CT scans of patients. Data is compared with recommendations of intraosseus needle producers to assess whether the information provided by the producers can be optimised. Study sites are head of humerus bone, distal femur, proximal and distal tibia in accordance with recommended intraosseus access sites. Data is gathered from patients who undergo either MRI or CT scanning for any disease and where bone at the IO puncture site is accessible for measurements required for this study. Primary and secondary outcome parameters will be assessed at one time only, i.e. when the patient has received MRI or CT scan for the diagnostic work up of their primary disease. Data collection for a given patient in this study can be completed within one session, e.g. 5-10 minutes. No additional investigation is required for this

Interventions

OTHERCT or MRI scan

CT or MRI performed for underlying disease. CT and MRI scans used to asses bone and soft tissue diameter

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

0 Years to 90 Years

Inclusion criteria

* Patients 0-90 years of age with elective or emergency MRI or CT scan within a 24 months period at the university hospital Innsbruck, Austria. Patients in analgosedation, anaesthesia, and stand-by

Exclusion criteria

* Pathologies at recommended intraosseus puncture - and investigation- site, i.e. proximal humerus, distal femur, proximal and distal tibia

Design outcomes

Primary

Measure	Time frame	Description
Soft tissue diameter	Retrospective single time measurement on MRI or CT scan. Measurement will last approx. 10 minutes, an will happen only once	CT or MRI performed for underlying disease. Diameter of soft tissue at the site of recommended intraosseus bone access

Secondary

Measure	Time frame	Description
Bone tissue diameter	Retrospective single time measurement on MRI or CT scan.Measurement will last approx. 10 minutes, an will happen only once	CT or MRI performed for underlying disease. Diameter of bone cortical and spongiosa at the site of recommended intraosseus bone access

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026